FIELD: medicine.
SUBSTANCE: invention relates to peptide analogues of formulae (I) and (II): (R2R3)- A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21A22-A23-A24-A25-A26-A27-A28-R1 in which A1-A28 and R2-R3 are defined in the description for each of the formulae (I) and (II), pharmaceutically acceptable salts thereof and pharmaceutical compositions containing an effective amount of formula (I) compounds and which can be used in the method of suppressing growth hormone secretion and a method of screening a compound which is capable of binding with the GHS receptor.
EFFECT: high efficiency of using the composition.
31 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR STIMULATING GASTROINTESTINAL MOTOR FUNCTION | 2006 |
|
RU2566708C2 |
| COMPOSITIONS AND METHODS FOR STIMULATION OF GASTROINTESTINAL TRACT LOCOMOTIVE FUNCTION | 2006 |
|
RU2420305C2 |
| GRELIN ANALOGS | 2003 |
|
RU2315059C2 |
| GHRELIN ANALOGUES | 2003 |
|
RU2373220C2 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| PEPTIDE DRUGS WITH HIGH EFFECTIVENESS AGAINST INSULIN RESISTANCE | 2012 |
|
RU2602801C2 |
| GLUCAGON ANALOGUES, POSSESSING HIGHER SOLUBILITY AND STABILITY IN BUFFERS WITH PHYSIOLOGICAL Ph VALUES | 2009 |
|
RU2560254C2 |
| METASTIN DERIVATIVES AND USE THEREOF | 2007 |
|
RU2454425C2 |
| DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | 2013 |
|
RU2652783C2 |
